Key Insights

Highlights

Success Rate

79% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

11.4%

4 terminated out of 35 trials

Success Rate

78.9%

-7.6% vs benchmark

Late-Stage Pipeline

14%

5 trials in Phase 3/4

Results Transparency

27%

4 of 15 completed with results

Key Signals

4 with results79% success

Data Visualizations

Phase Distribution

24Total
Not Applicable (8)
P 1 (3)
P 2 (8)
P 3 (2)
P 4 (3)

Trial Status

Completed15
Recruiting9
Terminated4
Unknown3
Active Not Recruiting2
Withdrawn2

Trial Success Rate

78.9%

Benchmark: 86.5%

Based on 15 completed trials

Clinical Trials (35)

Showing 20 of 20 trials
NCT00001467Recruiting

Genetic Analysis of Immune Disorders

NCT06612515RecruitingPrimary

Vaccine-induced Immunity in Immunocompromised Patients

NCT01861106Phase 2Recruiting

Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

NCT05027945Phase 2RecruitingPrimary

A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome

NCT06839456Phase 1Recruiting

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

NCT05587894Phase 2Recruiting

OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial

NCT07406217Phase 2Recruiting

OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients

NCT06098755Not ApplicableWithdrawn

The Sequestration of Holistic Stress Management Techniques for Adults

NCT06576024Phase 4Completed

Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in HIV-infected People

NCT05405491Not ApplicableActive Not Recruiting

Impact of a Strategy Based on Bacterial DNA Detection to Optimize Antibiotics in Immunocompromised Patients With Hospital-acquired Pneumonia Requiring Mechanical Ventilation

NCT04738812Phase 3Completed

Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression

NCT06634641Phase 4Recruiting

Clozapine-related Immunodeficiency in Parkinsons Disease

NCT04408950CompletedPrimary

Sample Collection for Systems Evaluation of Patients With Unknown or Incompletely Characterized Immune Defects

NCT05907746Phase 2Active Not Recruiting

Allogeneic Hematopoietic Stem Cell Transplantation With Briquilimab-Based Conditioning in Participants With GATA2 Deficiency

NCT04553705Phase 2Completed

Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19)

NCT05655546Not ApplicableTerminatedPrimary

ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals

NCT02291965Terminated

Blood Samples to Identify Biomarkers of Busulfan

NCT02274662Phase 4Completed

Expanded Access Protocol Thymus Transplantation

NCT05672654Not ApplicableWithdrawn

Evaluation of Post-SARS-CoV-2 Vaccinal Response in Immunocompromised Patients

NCT05461378CompletedPrimary

PREP (Pre-Exposure Prophylaxis) of COVID-19

Scroll to load more

Research Network

Activity Timeline